Xencor (XNCR) EBT Margin (2013 - 2026)

Xencor (XNCR) posted quarterly EBT Margin of 2848.45% for Q1 2026, down 270099.0% year-over-year from N/an in Q1 2025, and down 18754.12% quarter-over-quarter from 15.11% in Q4 2025.

Xencor (XNCR) EBT Margin (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported EBT Margin for 14 consecutive years, with 2848.45% the latest figure, recorded in Q1 2026.

  • In Q1 2026, EBT Margin fell 270099.0% year-over-year to 2848.45%; the TTM figure through Mar 2026 stood at 174.61% (down 1029.0% YoY), while the FY2025 annual figure was 71.38%, up 14124.0% from the prior year.
  • EBT Margin fell to 2848.45% in Q1 2026 per XNCR's latest filing, from 15.11% in the prior quarter.
  • Across five years, EBT Margin topped out at 30.16% in Q1 2022 and bottomed at 2848.45% in Q1 2026.
  • Historically, EBT Margin has averaged 299.26% across 5 years, with a median of 116.02% in 2022.
  • Annual changes were most pronounced in 2025 — EBT Margin surged 31586 bps — and 2026, when it tumbled 270099 bps.
  • Xencor's EBT Margin stood at 57.64% in 2022, then surged by 57 bps to 24.79% in 2023, then sank by 241 bps to 84.45% in 2024, then surged by 82 bps to 15.11% in 2025, then tumbled by 18754 bps to 2848.45% in 2026.
  • Business Quant data shows XNCR's EBT Margin at 2848.45% in Q1 2026, 15.11% in Q4 2025, and 28.7% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 35.61%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 34.77%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 18.33%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -94.22%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 13.77%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -2.67%
10 Xencor 1.73 Bn 1.36 Bn - -42.79%

Historic Data

Download Data
DateValue
Jun 30, 2026 -42.79%
Mar 31, 2026 -2,848.45%
Dec 31, 2025 -15.11%
Sep 30, 2025 -28.70%
Jun 30, 2025 -71.26%
Mar 31, 2025 -147.46%
Dec 31, 2024 -84.45%
Sep 30, 2024 -266.59%
Jun 30, 2024 -287.71%
Mar 31, 2024 -463.31%
Dec 31, 2023 -24.79%
Sep 30, 2023 -40.99%
Jun 30, 2023 -156.28%
Mar 31, 2023 -308.26%
Dec 31, 2022 -57.64%
Sep 30, 2022 -116.02%
Jun 30, 2022 -200.62%
Mar 31, 2022 30.16%
Dec 31, 2021 47.44%
Sep 30, 2021 -204.19%